Hemab Share Price

Hemab Share Price

NASDAQ: COAG | Healthcare
$39.37
-$0.28 (-0.71%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • About
  • Price history
  • FAQs

Hemab Stock Performance

Open
$39.50
Prev. Close
$39.65
Circuit Range
N/A
Day Range
$38.98 - $40.07
Year Range
$23.50 - $54.94
Volume
18,028
Average Traded
$39.57

Hemab Share Price Today

As of 22 November 2026, Hemab Therapeutics Holdings, Inc.'s share price is $39.37. The stock opened at $39.50, compared to its previous close of $39.65. During today's trading session, Hemab Therapeutics Holdings, Inc.'s share price traded between $38.98 and $40.07, with an average price of $39.52. Over the past 52 weeks, the stock has recorded a high of $54.94 and a low of $23.50. In terms of performance, Hemab Therapeutics Holdings, Inc.'s share price has risen by 38.68% over the last six months and is up 38.68% on a year-on-year basis.

Hemab Share Price Chart

Line chart of the Hemab price trend over the selected period. The price fell overall, ranging from 38.77 to 40.07, ending at 39.37.
$38.98$40.07
L
Show Current Price
H

Hemab Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.59
Revenue (TTM)
N/A
Return On Equity (TTM)
-17.27%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
N/A

Hemab Quarterly Profit & Loss

All figures in USD

ParticularsJun 2026Sep 2026
Revenue$0.00$0.00
Net Profit-$24.15-$27.30
Net Profit MarginN/AN/A
Income ChangeN/A-13.04%

About Hemab

Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.

Hemab Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$41.69
$39.33
-5.14%
Oct 2026
$30.64
$41.46
+33.79%
Sep 2026
$44.85
$30.99
-37.34%
Aug 2026
$46.71
$49.46
+4.61%
Jul 2026
$34.86
$47.28
+29.11%
Jun 2026
$27.53
$36.62
+28.99%
May 2026
$27.04
$28.39
N/A

Hemab Share Price FAQs